Unicycive Therapeutics (UNCY) Stock Chart & Stock Price History → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free UNCY Stock Alerts $1.08 -0.01 (-0.92%) (As of 05/15/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Unicycive Therapeutics Stock Price Performance5 Day Performance-4.42%1 Month Performance-4.00%3 Month Performance-21.17%6 Month Performance+110.44%Year-To-Date Performance+24.47%1 Year Performance-21.17% Receive UNCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsTiny AI projects with huge promise hiding in plain sight …I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. UNCY Stock Chart for Thursday, May, 16, 2024 UNCY Chart by TradingView Unicycive Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$1.09$1.08-0.92%$1.11$1.0871,647 shs$40.62 million05/14/2024$1.09$1.09$1.16$1.06147,427 shs$41.00 million05/13/2024$1.13$1.09-3.54%$1.14$1.0856,992 shs$41.00 million05/10/2024$1.08$1.13+4.63%$1.14$1.05278,502 shs$42.50 million05/09/2024$1.13$1.08-4.42%$1.14$1.01372,275 shs$40.62 million05/08/2024$1.16$1.13-2.59%$1.15$1.1170,275 shs$42.50 million Get the Latest News and Ratings for UNCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$1.18$1.16-1.69%$1.20$1.14149,758 shs$43.63 million05/06/2024$1.12$1.18+5.36%$1.21$1.10363,816 shs$44.38 million05/03/2024$1.12$1.12$1.15$1.11168,641 shs$42.12 million05/02/2024$1.14$1.12-1.32%$1.17$1.10238,990 shs$42.12 million05/01/2024$1.12$1.14+1.34%$1.16$1.11273,982 shs$42.12 million04/30/2024$1.22$1.12-8.20%$1.25$1.09523,099 shs$38.93 million04/29/2024$1.03$1.22+18.45%$1.29$1.011.99 million shs$42.41 million04/26/2024$0.97$1.03+6.19%$1.03$0.95232,305 shs$35.80 million04/25/2024$1.04$0.97-6.73%$1.05$0.93498,047 shs$33.72 million04/24/2024$1.07$1.04-2.80%$1.09$1.04179,329 shs$36.15 million04/23/2024$1.15$1.07-6.96%$1.19$1.07243,117 shs$37.19 million04/22/2024$1.07$1.15+7.48%$1.20$1.05458,697 shs$39.97 million04/19/2024$1.09$1.07-1.83%$1.13$1.04226,754 shs$37.19 million04/18/2024$1.16$1.09-5.63%$1.18$1.05893,190 shs$37.89 million04/17/2024$1.13$1.16+2.67%$1.16$1.12137,251 shs$40.15 million04/16/2024$1.14$1.13-1.32%$1.14$1.02535,343 shs$39.11 million04/15/2024$1.22$1.14-6.56%$1.24$1.101.07 million shs$39.63 million04/12/2024$1.25$1.22-2.40%$1.28$1.17410,594 shs$42.41 million04/11/2024$1.30$1.25-3.85%$1.35$1.25121,640 shs$43.45 million04/10/2024$1.32$1.30-1.52%$1.32$1.26168,586 shs$45.19 million04/09/2024$1.39$1.32-4.69%$1.39$1.29236,069 shs$45.88 million04/08/2024$1.42$1.39-2.46%$1.45$1.36204,243 shs$48.14 million04/05/2024$1.46$1.42-2.74%$1.49$1.37233,816 shs$49.36 million04/04/2024$1.37$1.46+6.57%$1.60$1.421.06 million shs$50.74 million04/03/2024$1.38$1.37-0.72%$1.40$1.33111,536 shs$47.62 million04/02/2024$1.41$1.38-2.13%$1.43$1.37980,019 shs$47.96 million04/01/2024$1.38$1.41+2.17%$1.52$1.36162,167 shs$49.00 million03/29/2024$1.38$1.38$1.48$1.38171,779 shs$47.96 million03/28/2024$1.46$1.38-5.48%$1.48$1.38171,379 shs$47.96 million03/27/2024$1.45$1.46+0.69%$1.47$1.4379,435 shs$50.74 million03/26/2024$1.52$1.45-4.61%$1.56$1.42221,173 shs$50.39 million03/25/2024$1.47$1.52+3.40%$1.60$1.45334,604 shs$52.82 million03/22/2024$1.33$1.47+10.53%$1.48$1.32359,330 shs$51.08 million03/21/2024$1.42$1.33-6.34%$1.43$1.32161,222 shs$46.22 millionBiden to Drop BOMBSHELL June 13th? (Ad)Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th!Click here now to see his shocking evidence.03/20/2024$1.39$1.42+2.16%$1.45$1.39293,298 shs$49.35 million03/19/2024$1.43$1.39-2.80%$1.47$1.39266,297 shs$48.31 million03/18/2024$1.46$1.43-2.05%$1.51$1.42201,723 shs$49.69 million03/15/2024$1.44$1.46+1.39%$1.52$1.41364,342 shs$50.74 million03/14/2024$1.39$1.44+3.60%$1.73$1.441.71 million shs$50.05 million03/13/2024$1.43$1.39-2.80%$1.47$1.38152,843 shs$48.30 million03/12/2024$1.49$1.43-4.03%$1.51$1.33273,049 shs$49.69 million03/11/2024$1.52$1.49-1.97%$1.55$1.47117,116 shs$51.78 million03/08/2024$1.50$1.52+1.33%$1.55$1.39392,538 shs$52.82 million03/07/2024$1.53$1.50-1.96%$1.56$1.48721,864 shs$52.13 million03/06/2024$1.47$1.53+4.08%$1.56$1.44196,341 shs$53.17 million03/05/2024$1.49$1.47-1.34%$1.55$1.40140,485 shs$51.09 million03/04/2024$1.60$1.49-6.88%$1.66$1.47390,538 shs$51.78 million03/01/2024$1.38$1.60+15.94%$1.63$1.39519,390 shs$55.60 million02/29/2024$1.41$1.38-2.13%$1.41$1.38232,250 shs$47.96 million02/28/2024$1.50$1.41-6.00%$1.51$1.25684,483 shs$49.00 million02/27/2024$1.58$1.50-5.06%$1.60$1.48223,424 shs$52.13 million02/26/2024$1.79$1.58-11.73%$1.80$1.211.24 million shs$54.91 million02/23/2024$1.75$1.79+2.29%$1.80$1.61348,608 shs$62.20 million02/22/2024$1.64$1.75+6.71%$1.82$1.51759,216 shs$60.81 million02/21/2024$1.46$1.64+12.33%$1.65$1.38509,052 shs$56.99 million02/20/2024$1.37$1.46+6.57%$1.52$1.30641,701 shs$50.74 million02/19/2024$1.37$1.37$1.44$1.26419,000 shs$47.61 million02/16/2024$1.31$1.37+4.58%$1.44$1.26412,840 shs$47.61 million02/15/2024$1.16$1.31+12.93%$1.33$1.17455,316 shs$45.53 million Related Companies: Xilio Therapeutics Stock Price Chart VYNE Therapeutics Stock Price Chart CASI Pharmaceuticals Stock Price Chart Eyenovia Stock Price Chart Gain Therapeutics Stock Price Chart Lexaria Bioscience Stock Price Chart Cara Therapeutics Stock Price Chart HCW Biologics Stock Price Chart Ocuphire Pharma Stock Price Chart Sensei Biotherapeutics Stock Price Chart Receive UNCY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:UNCY) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsThis unknown company solves the biggest issue with AIManward PressTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.